Clinical Trial Update: An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating 64Cu-DOTA-Trastuzumab PET/MRI for imaging HER2-positive breast cancer with brain metastases; currently recruiting at City of Hope Medic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• 64Cu-DOTA-Trastuzumab (Copper-64 DOTA-Trastuzumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 4 | Status: RECRUITING